Orlistat

• CAT Number: A000657
• CAS Number: 96829-58-2
• Molecular Formula: C₂₉H₅₃NO₅
• Molecular Weight: 495.73
• Purity: 98%
• Synonyms: 96829-58-2; Tetrahydrolipstatin; Xenical; Alli; Orlipastat
• Target: Apoptosis
• Storage: -20°C
• IUPAC Name: [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate
• InChI: InChI=1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27-/m0/s1
• InChIKey: AHLBNYSZXLDEJQ-FWEHEUNISA-N
• SMILES: CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O

Orlistat（Cat No.:A000657）is a lipase inhibitor widely used in managing obesity by reducing dietary fat absorption. It acts in the gastrointestinal tract, inhibiting pancreatic and gastric lipases, enzymes responsible for breaking down fats. By preventing fat digestion, Orlistat lowers calorie intake, promoting weight loss and improving metabolic health. Additionally, Orlistat has shown benefits in managing conditions like type 2 diabetes, hypertension, and dyslipidemia linked to obesity. Its localized action in the GI tract minimizes systemic effects, making it a preferred option for weight management and metabolic disease research.